Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action

@article{Lopresti2014SaffronS,
  title={Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action},
  author={Adrian L Lopresti and P. Drummond},
  journal={Human Psychopharmacology: Clinical and Experimental},
  year={2014},
  volume={29},
  pages={517 - 527}
}
  • Adrian L Lopresti, P. Drummond
  • Published 2014
  • Medicine
  • Human Psychopharmacology: Clinical and Experimental
  • BACKGROUND Saffron, a spice derived from the flower of Crocus sativus, has now undergone several trials examining its antidepressant effects and, in a recent meta-analysis, was confirmed to be effective for the treatment of major depression. [...] Key MethodDESIGN In the systematic review of clinical trials, electronic databases were searched for high-quality, randomised, double-blind studies, with placebo or antidepressant controls.Expand Abstract
    89 Citations
    Safety and Efficacy of Saffron (Crocus sativus L.) for Treating Mild to Moderate Depression
    • 1
    Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis.
    • 11
    • PDF
    Nutritional and health beneficial properties of saffron (Crocus sativus L): a comprehensive review.

    References

    SHOWING 1-10 OF 107 REFERENCES
    Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double‐blind, randomised and placebo‐controlled trial
    • 153
    • PDF
    Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.
    • 77
    • Highly Influential
    • PDF
    Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study
    • 76
    Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial
    • 249
    • Highly Influential
    • PDF
    Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
    • 223
    • Highly Influential
    Crocus sativus L.
    • 196
    • Highly Influential
    • PDF
    Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16‐week, randomized and placebo‐controlled trial
    • 145
    • PDF
    Anti-inflammatory properties of drugs from saffron crocus.
    • 76